Abstract
The ongoing COVID-19 pandemic urgently requires the availability of interventions that improve outcomes for those with severe disease. Since SARS-CoV-2 infection is characterised by dysregulated lung mucosae, and that mucosal homeostasis is heavily influenced by IL-13 activity, we explore recent findings indicating that IL-13 production is proportional to disease severity. Read more at jctres.com
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
